Chelsea Therapeutics International, Ltd. 4
4 · Chelsea Therapeutics International, Ltd. · Filed May 31, 2006
Insider Transaction Report
Form 4
Hewitt L Arthur
Vice Pres. of Drug Development
Transactions
- Exercise/Conversion
Common Stock
2006-05-26$0.03/sh+58,683$1,502→ 58,683 total - Exercise/Conversion
Stock Option (Right to Buy)
2006-05-26−58,683→ 0 totalExercise: $0.03Exp: 2014-05-03→ Common Stock (58,683 underlying)
Holdings
- 50,000
Stock Option (Right to Buy)
Exercise: $3.26Exp: 2016-01-19→ Common Stock (50,000 underlying) - 68,923
Stock Option (Right to Buy)
Exercise: $2.62Exp: 2015-01-10→ Common Stock (68,923 underlying)
Footnotes (4)
- [F1]The shares obtained upon exercise of the stock option agreement are restricted shares not registered for resale.
- [F2]Option vested in two equal annual installments beginning on May 3, 2005.
- [F3]Option vests in four equal annual installments beginning on January 19, 2007.
- [F4]Option vests in two equal annual installments beginning on January 10, 2006.